Myeloma Minute: Good News, Bad News in Current Science Climate
| INNOVATION | Latest Research Silver Linings Soften Spate of Science Program Budget CutsRecent budget cuts have hit programs that monitor toxic exposure, investigate climate change, and speed scientific discoveries. Fortunately, IMF Chairman Dr. Brian G.M. Durie finds lots of exciting new research, including a way to bring a long-extinct bird back to life. |
|
| INNOVATION | Clinical Trials |
| EDUCATION | Awareness |
Phase III Isatuximab Clinical Trials |
Racial Disparities in Myeloma Care |
Two new phase III clinical trials of isatuximab, an anti-CD38 monoclonal antibody, are enrolling myeloma patients. The IKEMA study assesses the clinical benefit of isatuximab combined with Kyprolis® and dexamethasone in patients with relapsed and/or refractory disease previously treated with one to three prior lines of therapy. The IMROZ study assesses the clinical benefit of isatuximab in combination with Velcade®, Revlimid®, and dexamethasone in patients with newly diagnosed myeloma not eligible for transplant. |
Cancer Therapy Advisor interviews the author of the first comprehensive study of racial disparities in the diagnosis and treatment of myeloma. “The picture is complex and, clearly, much needs to be done to improve access to ideal care,” says IMF Chairman Brian G.M. Durie. |
| ACTION | Advocacy IMF Advocacy Team Relaunches CoalitionOn Tuesday, March 6, 2018, the Patients Equal Access Coalition (PEAC), which is run by the IMF advocacy department, held an event in Washington, D.C. to relaunch the coalition as the Coalition to Improve Access to Cancer Care (CIACC). The relaunch effort will enhance our ability to pass legislation that would prevent insurance companies from applying different co-pays to oral cancer medicine than they do to chemotherapy or other injected treatments through H.R. 1409, the Cancer Drug Parity Act of 2017. The CIACC launched with a new name, logo and website as well as a major awareness campaign on Capitol Hill held on March 7th. Learn more about legislation, relaunch, and the Hill day. |
|
| EMPOWERMENT | Myeloma Action Month Add a Myeloma Warrior Frame to Your Facebook Profile PhotoThis year’s Myeloma Action Month campaign focuses on individuals like YOU who are surviving with the disease, supporting loved ones, or helping to find the cure. Remember to add an official Myeloma Warrior frame to your Facebook (FB) profile photo. Here’s how: 1) STEP 1: LIKE the International Myeloma Foundation Facebook page at https://www.facebook.com/myeloma/ 2) STEP 2:
|
|
| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series |
|
CLINICAL TRIALS |
EVENTS |
New isatuximab Clinical Trial: the IMROZ Study New isatuximab Clinical Trial: the IKEMA Study New ixazomib Clinical Trials: Learn How to Participate Join the conversation about myeloma on the Smart Patients Message Board |
March 10, 2018 March 10, 2018 March 16-17, 2018 April 8, 2018 April 21, 2018 April 28, 2018 May 5-6, 2018
|
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year